# Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension Patients

> **NCT03038451** · PHASE4 · COMPLETED · sponsor: **Neutec Ar-Ge San ve Tic A.Ş** · enrollment: 43 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** S-NOR (s-amlodipine) 2,5 mg & 5 mg tablet

## Key facts

- **NCT ID:** NCT03038451
- **Lead sponsor:** Neutec Ar-Ge San ve Tic A.Ş
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-20
- **Primary completion:** 2017-02-14
- **Final completion:** 2017-02-14
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2018-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03038451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03038451, "Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03038451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*